The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Palbociclib (PAL) + letrozole (L) as first-line (1L) therapy (tx) in estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Efficacy and safety across patient (pt) subgroups.

Richard S.  Finn

Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis; Pfizer

Research Funding - Pfizer (Inst)

Veronique  Dieras

Consulting or Advisory Role - Abbvie; Genentech; Lilly; Novartis; Pfizer; Roche

Speakers' Bureau - Novartis; Pfizer; Roche

Travel, Accommodations, Expenses - Novartis; Pfizer; Roche

Hope S.  Rugo

Honoraria - Genomic Health

Speakers' Bureau - Genomic Health

Research Funding - Celsion (Inst); Clovis Oncology (Inst); Eisai (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Plexxikon (Inst)

Travel, Accommodations, Expenses - Bayer; Novartis; OBI Pharma; Pfizer; Roche/Genentech

Anil A.  Joy

Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche

Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; Pfizer; Roche

Travel, Accommodations, Expenses - Novartis

Stacy L.  Moulder

Honoraria - Novartis

Research Funding - Bayer (Inst); Genentech (Inst); Novartis (Inst); Oncothyreon (Inst); Pfizer (Inst); Takeda (Inst)

Travel, Accommodations, Expenses - Novartis

Janice Maria  Walshe

Honoraria - Boehringer Ingelheim; Pfizer; Roche

Consulting or Advisory Role - Boehringer Ingelheim; Pfizer; Roche

Speakers' Bureau - Roche

Hirofumi  Mukai

Honoraria - AstraZeneca; Eisai; Novartis; Pfizer; Taiho Pharmaceutical

Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Nippon Kayaku (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)

Yaroslav V.  Shparyk

No Relationships to Disclose

In Hae  Park

No Relationships to Disclose

Ave  Mori

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Dongrui (Ray)  Lu

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Eric Roland  Gauthier

Employment - Pfizer

Stock and Other Ownership Interests  - Pfizer

Travel, Accommodations, Expenses - Pfizer

Karen A.  Gelmon

Consulting or Advisory Role - AstraZeneca; Merck; NanoString Technologies; Novartis; Pfizer